Published on 23/12/2025
How to Choose Between Open Access and Subscription-Based Journals for Clinical Manuscripts
One of the most critical decisions for clinical trial professionals and medical writers is choosing the right journal for manuscript submission. With the growth of scientific publishing, authors must navigate between open access (OA) and subscription-based journals. Each option has unique advantages and trade-offs related to accessibility, visibility, cost, and compliance.
This guide walks you through how to evaluate and select the most appropriate publishing model based on your research goals, target audience, sponsor requirements, and journal characteristics. It aligns with evolving expectations from regulators like EMA for greater transparency and public availability of clinical trial data.
Understanding the Two Publishing Models:
Open Access Journals:
OA journals make articles freely available to all readers without subscription. Authors usually pay an Article Processing Charge (APC).
- Free public access immediately upon publication
- High visibility and global reach
- Authors retain copyright under Creative Commons licenses
- Often supported by universities, funders, or government mandates
- APC may be waived for some authors (low-income countries, grants)
Subscription-Based Journals:
These journals restrict access to paying subscribers. Authors generally do not pay to publish.
- Access limited to subscribers or institutions
- No APC, but may charge
Key Factors to Consider When Choosing:
1. Target Audience Reach:
If your research is intended to influence global practice, guidelines, or policymaking, OA maximizes readership. Readers in resource-limited settings without institutional subscriptions can freely access your work. OA is highly recommended for Stability Studies or trial results with public health relevance.
2. Sponsor and Funder Requirements:
Many public and private sponsors now mandate OA publishing. Examples include:
- NIH (USA), Wellcome Trust, Bill & Melinda Gates Foundation
- EU Horizon 2020 and similar research initiatives
- Pharma companies promoting transparency of trial data
Check the sponsor’s publication policy before choosing a journal.
3. Budget and Publication Charges:
OA journals charge APCs ranging from $500 to $5000 depending on the journal’s impact factor and publisher. While some journals offer waivers, authors without funding may struggle with these fees. In contrast, subscription-based journals usually do not charge authors (though page/figure fees may apply).
Some hybrid journals offer both models—subscription with optional OA by paying APCs.
4. Journal Impact and Indexing:
Subscription-based journals often have longer histories and higher impact factors, making them attractive for career progression. However, many OA journals (e.g., PLOS ONE, BMC, Frontiers) are now indexed in PubMed, Scopus, and have strong citation metrics.
Whether you publish OA or not, ensure the journal is peer-reviewed and indexed in reputable databases to preserve scientific credibility.
Advantages of Open Access Publishing:
- Increased visibility and citations
- Faster dissemination of results
- Supports equity and democratization of knowledge
- Mandatory under many transparency frameworks for clinical research
- Enables public scrutiny and ethical accountability of pharma trials
Studies have shown that OA articles receive significantly more downloads and social media engagement compared to paywalled ones.
Limitations and Risks of Open Access:
- High APCs may not be affordable without grant support
- Quality varies widely across OA journals—watch for predatory publishers
- Newer OA journals may lack established impact metrics
- Peer-review timelines may be shorter, but not always transparent
To avoid predatory journals, check membership in DOAJ, COPE, and publisher reputation before submission.
When to Prefer Subscription-Based Journals:
Choose a subscription-based journal if:
- You’re targeting a high-impact, field-specific audience
- Your institution has access to that journal and broad readership
- You have no funds for APCs and no mandate for OA
- Your manuscript addresses niche regulatory issues (e.g., pharma regulatory requirements)
Comparison Table: Open Access vs Subscription
| Feature | Open Access | Subscription-Based |
|---|---|---|
| Access Model | Free to all | Paid or institutional access only |
| Author Charges | Yes (APC) | Usually none |
| Visibility | Global and high | Limited to subscribers |
| Retention of Rights | Often retained by author | Transferred to publisher |
| Speed to Publication | Often faster | May take longer |
| Indexing | High in quality journals | High |
| Prestige | Variable | Generally higher |
Hybrid Journals – A Middle Ground:
Many high-impact journals now offer OA options under a hybrid model. Authors can choose to publish OA by paying APCs or go the traditional route. These provide the best of both worlds—prestige and accessibility.
Examples: The Lancet, NEJM, JAMA Network Open
Best Practices for Choosing the Right Journal:
- Match your manuscript topic with the journal scope and audience
- Check indexing and peer review rigor
- Evaluate APCs and funding availability
- Ensure ethical publishing policies (COPE member, transparent fees)
- Confirm compliance with sponsor or institutional mandates
You can also refer to publishing support resources on Pharma SOPs and follow guidelines for manuscript preparation based on validation master plans or trial protocols.
Conclusion:
There is no one-size-fits-all answer when choosing between open access and subscription-based journals. The best choice depends on your manuscript’s audience, funding support, sponsor policy, and strategic goals. Open access enhances global reach and aligns with current trends in GMP compliance transparency, while subscription journals may offer prestige and history.
Make an informed decision based on journal quality, accessibility, and your publishing priorities. A well-placed manuscript can maximize impact, citations, and influence in the pharmaceutical and clinical research community.